Nasal spray painkiller for children with sickle cell pain crisis
Treatments studied
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial tests a special painkiller called sufentanil given as a nasal spray to children with sickle cell disease who are having a severe pain crisis. It aims to see if this nasal spray works better or as well as usual pain treatment to quickly reduce pain in the emergency room.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must have sickle cell disease (any type: SS, SC, or S-beta thalassemia)
- Must be younger than 18 years old
- Must weigh more than 10 kilograms (about 22 pounds)
- Must be having severe pain from a sickle cell crisis at the time of the study
- Must not have taken strong painkillers (like morphine) in the last 6 hours
- Must not have certain health conditions like severe asthma, liver or kidney failure, or a recent nose injury
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different ways to manage sickle cell pain crises in the hospital, using a flexible 'platform' design to test combinations of pain medicines. It aims to find the safest and most effective approach to reduce pain and improve recovery.
This study compares two different nasal spray pain medicines (sufentanil and ketamine) to see which works better and is safer for children with severe pain from injuries, like a broken arm or leg.
This trial tests whether a numbing medicine (lidocaine) given through a vein can help reduce the amount of strong painkillers (morphine or oxycodone) needed for a sickle cell pain crisis or acute chest syndrome. It aims to ease pain and possibly lower side effects from opioids.
This study tests whether a low-dose of ketamine (a pain medicine) can help children and young adults with sickle cell disease who are in a pain crisis. It aims to provide better pain relief while avoiding some side effects of standard painkillers.
This trial tests an intravenous medicine called L-citrulline for young people with sickle cell disease who are in the emergency department for a painful crisis (vaso-occlusive crisis). It aims to see if it can ease the pain and help you recover faster.
This trial tests if an intravenous medication called L-citrulline can help treat pain crises in children and young adults with sickle cell disease. Participants receive either the study drug or a placebo while in the hospital for a severe pain episode.
Hear when a new Vaso-occlusive Crisis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.